Entities / Company
DAXOR.
Czech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.Some support1 report
-
FDA clearance enables market access for a new device from DAXOR.Some support2 reports
-
Daxor received FDA clearance for its diagnostic and presented findings in New York City.Some support4 reports
-
DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around DAXOR this week
News at the entities that move DAXOR most-
FDA StructuralPenumbra was acquired by Boston Scientific in a $14.5bn deal, and the company gained clearance for its Thunderbolt product line.Moves DAXOR
-
Food and Drug Administration StructuralFDA ordered the recall of a batch of cow ghee from Patanjali Foods Limited in Madhya Pradesh.Moves DAXOR
-
New York City Shared contextA lawsuit was filed in New York City against Build-A-Bear Workshop on November 1, 2026.Moves DAXOR
-
Kansas Shared contextTriebold Paleontology discovered a fossil for the Sternberg Museum of Natural History, which is managed by Fort Hays State University in Kansas.Moves DAXOR
Connections
The 7 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
DAXOR's market access and product function are formally dependent on receiving regulatory clearance from the FDA.
-
BVA Structural
Daxor utilizes BVA's technology for volume measurement, establishing a functional dependency.
-
Food and Drug Administration Structural
DAXOR's analyzer requires clearance from the FDA to enable blood volume testing.
-
Duke University Medical Center Structural
Daxor's technology is validated by Duke University Medical Center research, which Daxor then uses in its public announcements.
-
American College of Cardiology Shared context
Daxor presented technology and data at American College of Cardiology events.
-
Kansas Shared context
DAXOR operates within the geographic and regulatory context of Kansas.
-
New York City Shared context
DAXOR operates within the context of New York City, utilizing it as a location for professional conferences.
History
Events by the month they beganOctober 2026
1 eventJune 2026
4 events- DAXOR is expanding into a Tennessee medical center, integrating BVA with on-site analyzer for heart failure services.
- FDA clearance enables market access for a new device from DAXOR.
- Daxor received FDA clearance for its diagnostic and presented findings in New York City.
- DAXOR's technology was validated in Jan Bakker's study, and ATR was identified as a measure of fluid leakage technology.